Science
Mechanism of Action
This peptide functions as an allosteric inhibitor, precisely targeting and blocking the pores of KCa2/SK channels, thereby suppressing delayed cellular hyperpolarization. This mechanism reduces the expression and release of pro-inflammatory cytokines, such as TNFα and IL-6. Further research suggests S-APAMIN SP may also possess antioxidant and anti-apoptotic capabilities, contributing to its observed anti-inflammatory and anti-fibrotic effects.
Research
Clinical Evidence
Low confidenceN/A
Key findings
- 01 Potent and highly selective inhibition of KCa2.2 SK channels (IC50: 87.7 pM), KCa2.3 SK channels (IC50: 2.3 nM), and KCa2.1 SK channels (IC50: 4.1 nM).
- 02 Reduced expression of α-SMA in TGF-β1-induced HSC-T6 cells, indicating anti-fibrotic activity, at concentrations of 0.5-2 μg/mL.
- 03 Reduced release and mRNA expression of inflammatory cytokines TNFα and IL-6, with potential anti-oxidative and anti-apoptotic activities. Concentration for skin application not specified.
Transparency
Dusting Analysis
S-APAMIN SP is primarily a research chemical with significant toxicity and is not utilized as a cosmetic ingredient. Therefore, the concept of 'dusting' in cosmetic formulations is not applicable.
The Formula
Formulation
Stability
S-APAMIN SP is a strongly basic peptide. In powder form, it requires protection from moisture. For storage, -20°C for up to 3 years is recommended for powder, and -80°C for up to 6 months for solutions. Optimal pH for cosmetic formulations is not available, though various pH levels (3.2, 7.2, 7.4) have been used in research settings.
Safety
Safety Profile
S-APAMIN SP is a neurotoxin derived from bee venom, exhibiting significant toxic effects including optic neuritis, atrial fibrillation, cerebral infarction, acute myocardial infarction, and various neurological syndromes reported in poisoning incidents. The intravenous LD50 in mice is 6.00 mg/kg, indicating an extremely narrow therapeutic window. It has not been reviewed by CIR or SCCS for cosmetic safety, and no FDA status for cosmetic use was found. Products containing Apamin are generally designated for research purposes only and are not for human consumption. INCIDecoder also reports high irritancy.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite observed anti-inflammatory and anti-fibrotic potential in research, S-APAMIN SP's significant neurotoxicity and complete lack of safety approval for cosmetic applications make it unsuitable and unsafe for skincare formulations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources